Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location | |
|---|---|---|---|---|
|
Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP) |
Primary Immune Thrombocytopenia (ITP) | Phase3 |
Argentina Australia Belgium China Czechia France Germany Malaysia Singapore Spain United Kingdom United States View All
|
NCT05653349 |
|
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer |
Prostate Cancer | Phase4 |
Austria Belgium Canada Czechia France Germany Netherlands Spain Sweden United Kingdom United States View All
|
NCT05803941 |
|
A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia |
Warm Autoimmune Hemolytic Anemia (wAIHA) | Phase3 |
Argentina Australia China France Germany Israel Italy Japan Spain United Kingdom United States View All
|
NCT05648968 |
|
Study of MGY825 in Patients With Advanced Non-small Cell Lung Cancer |
Non-small Cell Lung Cancer | Phase1 |
Germany Japan South Korea Spain Switzerland United States View All
|
NCT05275868 |
|
Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR) |
Polymyalgia Rheumatica | Phase3 |
Argentina Australia Belgium Brazil Canada Chile Colombia Czechia Denmark France Germany Hungary Israel Italy Japan Mexico Netherlands Poland South Africa Spain Switzerland United Kingdom United States View All
|
NCT06331312 |
|
Ribociclib Real-world Treatment Patterns and Clinical Outcomes Among Women With HR+/HER2- Advanced or Metastatic Breast Cancer in France |
Breast Cancer | France | NCT05697146 | |
|
Revolade Tablets Specified Drug-use Survey |
Aplastic Anemia | Japan | NCT06287268 | |
|
Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases |
Myeloid Diseases | Phase1 |
France Germany Hong Kong Italy Singapore Spain United States View All
|
NCT05552469 |
|
Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease |
Steroid-refractory Acute Graft Versus Host Disease | Phase4 | China | NCT06462469 |
|
A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor. |
Breast Cancer | Phase1, Phase2 |
Australia Canada China France Germany Italy Netherlands Portugal Singapore South Korea Spain United Kingdom United States View All
|
NCT06247995 |